Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid Tumors.
de Braud F, Machiels JH, Boggiani D, Rottey SWH, Duca M, Laruelle M, Salvagni S, Damian S, Lapeire LDF, Tiseo M, Dermine A, Ould-Kaci M, Braunger J, Rascher J, Fischer D, Hoefler J, Mariani GL, Cresta S. de Braud F, et al. Among authors: hoefler j. Cancers (Basel). 2020 May 31;12(6):1425. doi: 10.3390/cancers12061425. Cancers (Basel). 2020. PMID: 32486385 Free PMC article.
Dose-response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial.
Blüher M, Rosenstock J, Hoefler J, Manuel R, Hennige AM. Blüher M, et al. Among authors: hoefler j. Diabetologia. 2024 Mar;67(3):470-482. doi: 10.1007/s00125-023-06053-9. Epub 2023 Dec 14. Diabetologia. 2024. PMID: 38095657 Free PMC article. Clinical Trial.
Correction to: Dose-response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial.
Blüher M, Rosenstock J, Hoefler J, Manuel R, Hennige AM. Blüher M, et al. Among authors: hoefler j. Diabetologia. 2024 Apr;67(4):758. doi: 10.1007/s00125-024-06095-7. Diabetologia. 2024. PMID: 38349400 Free PMC article. No abstract available.
Creating Solid Solutions of Metallocenes: Migration of Nickelocene into the Ferrocene Crystal Lattice in the Absence of a Solvent.
Harmon-Welch GE, Hoefler JC, Trujillo MR, Bhuvanesh N, Bakhmutov VI, Blümel J. Harmon-Welch GE, et al. Among authors: hoefler jc. J Phys Chem C Nanomater Interfaces. 2023 Feb 6;127(6):3059-3066. doi: 10.1021/acs.jpcc.2c07441. eCollection 2023 Feb 16. J Phys Chem C Nanomater Interfaces. 2023. PMID: 38333002 Free PMC article.
Cognitive behavioral therapy for insomnia, but not armodafinil, improves fatigue in cancer survivors with insomnia: a randomized placebo-controlled trial.
Heckler CE, Garland SN, Peoples AR, Perlis ML, Shayne M, Morrow GR, Kamen C, Hoefler J, Roscoe JA. Heckler CE, et al. Among authors: hoefler j. Support Care Cancer. 2016 May;24(5):2059-2066. doi: 10.1007/s00520-015-2996-y. Epub 2015 Nov 5. Support Care Cancer. 2016. PMID: 26542272 Free PMC article. Clinical Trial.
20 results